Parathyroid hormone Subcutaneous and Tofacitinib Extended-Release Tablets
Determining the interaction of Parathyroid hormone Subcutaneous and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: parathyroid hormone
Brand name: Natpara
Synonyms: Parathyroid hormone, Parathyroid Hormone
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Parathyroid hormone Subcutaneous-Tofacitinib Tablets
- Parathyroid hormone Subcutaneous-Tofranil
- Parathyroid hormone Subcutaneous-Tofranil injection
- Parathyroid hormone Subcutaneous-Tofranil-PM
- Parathyroid hormone Subcutaneous-Tol-Tab
- Parathyroid hormone Subcutaneous-Tolazamide
- Tofacitinib Extended-Release Tablets-Parcopa
- Tofacitinib Extended-Release Tablets-Paregoric
- Tofacitinib Extended-Release Tablets-Paremyd
- Tofacitinib Extended-Release Tablets-Paremyd Ophthalmic
- Tofacitinib Extended-Release Tablets-Paricalcitol
- Tofacitinib Extended-Release Tablets-Paricalcitol Capsules